Evaluation of Acute Myeloid Leukemia by high parameter flow cytometry

Presented by

Greg Bannish, PhD, Flow Cytometry Subject Matter Expert, Champions Oncology

About this talk

Acute Myeloid leukemia (AML) is a specific type of cancer in which the bone marrow makes abnormal myeloblasts, red blood cells and platelets. AML is the most prevalent acute leukemia in adults. Champions Oncology has developed and optimized an 18-color Comprehensive AML Flow Cytometry panel for use in preclinical primary AML models and for exploratory clinical studies. This webinar will walk through the development of the panel and its uses from the bench to the clinic. Learning points for this webinar: • Use of flow cytometry in detection of AML • Delineation of phenotype markers in different AML subtypes • Detection of rare cell subsets and correlation with drug treatment

Related topics:

More from this channel

Upcoming talks (2)
On-demand talks (47)
Subscribers (2559)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.